Modulation of inflammatory genes by natural dietary bioactive compounds

Journal of Agricultural and Food Chemistry

Volumn 57, Issue 11, 2009, Pages 4467-4477

  Pan, Min Hsiung ^a   Lai, Ching Shu ^a   Dushenkov, Slavik ^b   Ho, Chi Tang ^b  

^a NATIONAL KAOHSIUNG UNIVERSITY OF APPLIED SCIENCES   (Taiwan)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

Chemoprevention; Inflammation; Inflammatory microenvironment; Natural bioactive compounds; Nutraceuticals

Indexed keywords

AUTACOID; BIOLOGICAL PRODUCT;

ANIMAL; DIET THERAPY; GENE EXPRESSION; GENETICS; HUMAN; IMMUNOLOGY; INFLAMMATION; NEOPLASM; REVIEW;

ANIMALS; BIOLOGICAL PRODUCTS; GENE EXPRESSION; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; NEOPLASMS;

EID: 67149146566     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf900612n     Document Type: Review

References (94)

1. Lila, M. A.; Raskin, I. Health-related interactions of phytochem-icals. J. Food Sci. 2005, 70, R20-R27.
2. Evans, D. A.; Hirsch, J. B.; Dushenkov, S. Phenolics, inflammation, and nutrigenomics. J. Sci. Food Agric. 2006, 86, 2503-2509.
3. Scalbert, A.; Knasmuller, S. Genomic effects of phytochemicals and their implication in the maintenance of health. Br. J. Nutr. 2008, 99 (E. Suppl. 1), ES1-ES2.
4. Subbiali, M. T. Understanding the nutrigenomic definitions and concepts at the food-genome junction. OMJCS 2008, 12 (4), 229-235.
5. Pan, M. H.; Ghai, G.; Ho, C. T. Food bioactives, apoptosis, and cancer. Mol. Nutr. Food Res. 2008, 52 (1), 43-52.
6. Mantovani, A.; Allavena, P.; Sica, A.; Balkwill, F. Cancer-related inflammation. Nature 2008, 454 (7203), 436-444.
7. Pan, M. H.; Ho, C. T. Chemopreventive effects of natural dietary compounds on cancer development. Chem. Soc. Rev. 2008, 57 (11), 2558-2574.
8. Ramos, S. Cancer chemoprevention and chemotherapy: dietary polyphenols and signalling pathways. Mol. Nutr. Food Res. 2008, 52 (5), 507-526.
9. D'lncalci, M.; Brunelli, D.; Marangon, E.; Simone, M.; Tavecchio, M.; Gescher, A.; Mantovani, R. Modulation of gene transcription by natural products - a viable anticancer strategy. Curr. Pharm. Des 2007, 13 (27), 2744-2750.
10. Medzhitov, R. Origin and physiological roles of inflammation. Nature 2008, 454 (7203), 428-435.
11. Aggarwal, B. B.; Vijayalekshmi, R. V.; Sung, B. Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe. Clin. Cancer Res. 2009, 15 (2), 425-430.
12. Lu, H.; Ouyang, W.; Huang, C. Inflammation, a key event in cancer development. Mol Cancer Res. 2006, 4 (4), 221-233.
13. Karin, M. Nuclear faetor-κB in cancer development and progression. Nature 2006, 441 (7092), 431-436.
14. Maeda, S.; Omata, M. Inflammation and cancer: role of nuclear faetor-κB activation. Cancer Sci. 2008, 99 (5), 836-842.
15. Agarwal, A.; Das, K.; Lerner, N.; Sathe, S.; Cicek, M.; Casey, G.; Sizemore, N. The AKT/I κ B kinase pathway promotes angiogenic/metastatic gene expression in colorectal cancer by activating nuclear factor-κ B and β-catenin. Oncogene 2005, 24 (6), 1021-1031.
16. Trayhurn, P. Northern blotting. Proc. Nutr. Soc. 1996, 55 (1B), 583-589.
17. Nguyen, T. T.; Smith, J. B. Ribonuclease protection assay streamlined for high throughput with RNA in formamide and single-step rnase inactivation. BioTechniques 2002, 32 (3), 502, 504, 506.
18. Salomon, R. N. Introduction to reverse transcription Polymerase Chain Reaction. Diagn. Mol. Pathol. 1995, 4 (1). 2-3.
19. Wong, M. L.; Medrano, J. F. Real-time PCR for mRNA quantita-tion. Bio Techniques 2005, 39 (1), 75-85.
20. Hughes, T. R.; Hiley, S. L.; Saltzman, A. L.; Babak, T.; Blencowe, B. J. Microarray analysis of RNA processing and modification. Methods Enzymol. 2006, 410, 300-316.
21. Das, P. M.; Ramachandran, K.; vanWert, J.; Singal, R. Chromatin immunoprecipitation assay. BioTechniques 2004, 37 (6), 961-969.
22. Lu, J.; Gosslau, A.; Liu, A. Y.; Chen, K. Y. PCR differential display-based identification of regulator of G protein signaling 10 as the target gene in human colon cancer cells induced by black tea polyphenol theaflavin monogallate. Eur. J. Pharmacol. 2008, 601 (1-3). 66-72.
23. Lansky, E. P.; Paavilainen, H. M.; Pawlus, A. D.; Newman, R. A. Ficus spp. (fig): ethnobotany and potential as anticancer and antiinflammatory agents. J. Ethnopharmacol. 2008, 119(2), 195-213.
24. Balick, M.; Lee, R. Inflammation and ethnomedicine: looking to our past. Explore (N.Y.) 2005, 1 (5), 389-392.
25. Subbaramaiah, K.; Bulc, P.; Lin, Y.; Dannenberg, A. J.; Pasco, D. S. Development and use of a gene promoter-based screen to identify novel inhibitors of cyclooxygenase-2 transcription. J. Biomol. Screen. 2001, 6 (2), 101-110.
26. Dey, M.; Ripoll, C.; Pouleva, R.; Dorn, R.; Aranovich, I.; Zaurov, D.; Kurmukov, A.; Eliseyeva, M.; Belolipov, 1.; Akimaliev, A.; Sodombekov, I.; Akimaliev, D.; Lila, M. A.; Raskin, I. Plant extracts from central Asia showing antiinflammatory activities in gene expression assays. Phytother. Res. 2008, 22 (7), 929-934.
27. Kao, T. H.; Wu, W. M.; Hung, C. F.; Wu, W. B.; Chen, B. H. Antiinflammatory effects of isoflavone powder produced from soybean cake. J. Agric. Food Chem. 2007, 55, 11068-11079.
28. Fang, J.; Xia, C.; Cao, Z.; Zheng, J. Z.; Reed, E.; Jiang, B. H. Apigenin inhibits VEGF and H1F-1 expression via PI3K/AKT; p70S6Kl and HDM2/p53 pathways. FASEB J. 2005, 19 (3), 342-353.
29. Nicholas, C.; Batra, S.; Vargo, M. A.; Voss, O. H.; Gavrilin, M. A.; Wewers, M. D.; Guttridge, D. C.; Grotewold, E.; Doseff, A. I. Apigenin blocks lipopolysaccharide-induced lethality in vivo and proinflammatory cytokines expression by inactivating NF-κB through the suppression of p65 phosphorylation. J. Imniunol. 2007, 179 (10), 7121-7127.
30. Van Dross, R. T.; Hong, X.; Essengue, S.; Fischer, S. M.; Felling, J. C. Modulation of UVB-induced and basal cyclooxygenase-2 (COX-2) expression by apigenin in mouse keratinocytes: role of USF transcription factors. Mol. Carcinog. 2007, 46 (4), 303-314.
31. Benavente-Garcia, O.; Castillo, J. Update on uses and properties of citrus flavonoids: new findings in anticancer, cardiovascular, and anti-inflammatory activity. J. Agric. Food Chem. 2008, 56, 6185-6205.
32. Manthey, J. A.; Bendele, P. Anti-inflammatory activity of an orange peel polymethoxylated flavone, 3′,4′,3,5,6,7,8-heptamethoxyflavone, in the rat carrageenan/paw edema and mouse lipopolysaccharide-challenge assays. J. Agric. Food Chem. 2008, 56, 9399-9403.
33. Held, S.; Schieberle, P.; Somoza, V. Characterization of α-terpineol as an anti-inflammatory component of orange juice by in vitro studies using oral buccal cells. J. Agric. Food Chem. 2007, 55, 8040-8046.
34. Chen, K. H.; Weng, M. S.; Lin, J. K. Tangeretin suppresses IL-1β-induced cyclooxygenase (COX)-2 expression through inhibition of p38 MAPK, JNK, and AKT activation in human lung carcinoma cells. Biochem. Pharmacol. 2007, 73 (2), 215-227.
35. Lai, C. S.; Li, S.; Chai, C. Y.; Lo, C. Y.; Ho, C. T.; Wang, Y. J.; Pan, M. H. Inhibitory effect of citrus 5-hydroxy-3,6,7,8,3′,4′-hexam- ethoxyflavone on 12-O-tetradecanoylphorbol 13-acetate-induced skin inflammation and tumor promotion in mice. Carcinogenesis 2007, 25(12), 2581-2588.
36. Hamalainen, M.; Nieminen, R.; Vuorela, P.; Heinonen, M.; Moilanen, E. Anti-inflammatory effects of flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-κB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-κB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages. Mediators Inflamm. 2007, 2007, 45673.
37. Crespo, I.; Garcia-Mediavilla, M. V.; Gutierrez, B.; Sanchez-Campos, S.; Tunon, M. J.; Gonzalez-Gallego, J. A comparison of the effects of kaempferol and quercetin on cytokine-indueed pro-inflammatory status of cultured human endothelial cells. Br. J. Nutr. 2008, 100 (5), 968-976.
38. Park, H. H.; Lee, S.; Son, H. Y.; Park, S. B.; Kim, M. S.; Choi, E. J.; Singh, T. S.; Ha, J. H.; Lee, M. G.; Kim, J. E.; Hyun, M. C.; Kwon, T. K.; Kim, Y. H.; Kim, S. H. Flavonoids inhibit histamine release and expression of proinflammatory cytokines in mast cells. Arch. Pharm. Res. 2008, 31 (10), 1303-1311.
39. Ruiz, P. A.; Braune, A.; Holzlwimmer, G.; Quintanilla-Fend, L.; Haller, D. Quercetin inhibits TNF-induced NF-κB transcription factor recruitment to proinflammatory gene promoters in murine intestinal epithelial cells, J. Nutr. 2007, 137(5), 1208-1215.
40. Bodet, C.; La, V. D.; Epifano, F.; Grenier, D. Naringenin has antiinflammatory properties in macrophage and ex vivo human whole-blood models. J. Periodontal Res. 2008, 43 (4), 400-407.
41. Sang, S.; Lambert, J. D.; Ho, C. T.; Yang, C. S. In Encyclopedia of Dietary Supplements; Coates, P., Blackman, M.R., Cragg, G. M., Levine, M., Moss, J., White, J. D., Eds.; Dekker: New York, 2005; pp 327-336.
42. Lee, K. W.; Kundu, J. K.; Kim, S. O.; Chun, K. S.; Lee, H. J.; Surh, Y. J. Cocoa polyphenols inhibit phorbol ester-induced superoxide anion formation in cultured HL-60 cells and expression of cycloox-ygenase-2 and activation of NF-κB and MAPKs in mouse skin in vivo. J. Nutr. 2006, 136 (5), 1150-1155.
43. Ahn, H. Y.; Xu, Y.; Davidge, S. T. Epigallocatechin-3-O-gallate inhibits TNFα-induced monocyte chemotactic protein-1 production from vascular endothelial cells. Life Sci. 2008, 82 (17-18), 964-968.
44. Wheeler, D. S.; Catravas, J. D.; Odoms, K.; Denenberg, A.; Malhotra, V.; Wong, H. R. Epigallocatechin-3-gallate, a green tea-derived polyphenol, inhibits IL-1 β-dependent proinflammatory signal transduc-tion in cultured respirator)' epithelial cells. J. Nutr. 2004, 134 (5), 1039-1044.
45. Kundu, J. K.; Surh, Y. J. Epigallocatechin gallate inhibits phorbol ester-induced activation of NF-κ B and CREB in mouse skin: role of p38 MAPK. Ann. N.Y. Acad. Sci. 2007, 1095, 504-512.
46. Ukil, A.; Maity, S.; Das, P. K. Protection from experimental colitis by theaflavin-3,3′-digallate correlates with inhibition of IKK and NF-κB activation. Br. J. Pharmacol. 2006, 149 (1), 121-131.
47. Cai, F.; Li, C. R.; Wu, J. L.; Chen, J. G.; Liu, C.; Min, Q.; Yu, W.; Ouyang, C. H.; Chen, J. H. Theaflavin ameliorates cerebral ische-mia-reperfusion injury in rats through its anti-inflammatory effect and modulation of STAT-1. Mediators Inflamm. 2006, 2006 (5), 30490.
48. Cornwell, T.; Cohick, W.; Raskin, I. Dietary phytoestrogens and health. Phytochemistry 2004, 65 (8), 995-1016.
49. Dijsselbloem, N.; Goriely, S.; Albarani, V.; Gerlo, S.; Francoz, S.; Marine, J. C.; Goldman, M.; Haegeman, G.; Vanden, B. W. A critical role for p53 in the control of NF-κB-dependent gene expression in TLR4-stimulated dendritic cells exposed to genistein. J. Immunol. 2007, 178 (8), 5048-5057.
50. Kesherwani, V.; Sodhi, A. Involvement of tyrosine kinases and MAP kinases in the production of TNF-α and 1L-1β by macrophages in vitro on treatment with phytohemagglutinin. J. Interferon Cytokine Res. 2007, 27 (6), 497-505.
51. Oak, M. H.; Bedoui, J. E.; Madeira, S. V.; Chalupsky, K.; Schini-Kerth, V. B. Delphinidin and cyanidin inhibit PDGF(AB)-induced VEGF release in vascular smooth muscle cells by preventing activation of p38 MAPK and JNK. Br. J. Pharmacol. 2006, 149 (3), 283-290.
52. Wang, Q.; Xia, M.; Liu, C.; Guo, H.; Ye, Q.; Hu, Y.; Zhang, Y.; Hou, M.; Zhu, H.; Ma, J.; Ling, W. Cyanidin-3-O-β-glucoside inhibits iNOS and COX-2 expression by inducing liver X receptor α activation in THP-1 macrophages. Life Sci. 2008, 83 (5-6), 176-184.
53. Ding, M.; Feng, R.; Wang, S. Y.; Bowman, L.; Lu, Y.; Qian, Y.; Castranova, V.; Jiang, B. H.; Shi, X. Cyanidin-3-glucoside, a natural product derived from blackberry, exhibits chemopreventive and chemotherapeutic activity. J. Biol. Cham. 2006, 281 (25), 17359-17368.
54. Lamy, S.; Beaulieu, E.; Labbe, D.; Bedard, V.; Moghrabi, A.; Barrette, S.; Gingras, D.; Beliveau, R. Delphinidin, a dietary anthocyanidin, inhibits platelet-derived growth factor ligand/receptor (PDGF/PDGFR) signaling. Carcinogenesis 2008, 29 (5), 1033-1041.
55. Parmar, M. Y.; Gandhi, T. R. Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine - a review. Phannacognosy Rev. 2008, 2, 102-109.
56. Ramasamy, K.; Agarwal, R. Multitargeted therapy of cancer by silymarin. Cancer Lett. 2008, 269 (2), 352-362.
57. Lee, J. S.; Kim, S. G.; Kim, H. K.; Lee, T. H.; Jeong, Y. I.; Lee, C. M.; Yoon, M. S.; Na, Y. J.; Suh, D. S.; Park, N. C.; Choi, I. H.; Kim, G. Y.; Choi, Y. H.; Chung, H. Y.; Park, Y. M. Silibinin polarizes Thl/Th2 immune responses through the inhibition of immunosti-mulatory function of dendritic cells. J. Cell Physiol 2007, 210 (2), 385-397.
58. Gu, M.; Singh, R. P.; Dhanalakshmi, S.; Agarwal, C.; Agarwal, R. Silibinin inhibits inflammatory and angiogenic attributes in photocarcinogenesis in SKH-1 hairless mice, Cancer Res. 2007, 67 (7), 3483-3491.
59. Lin, W.; Wu, R. T.; Wu, T.; Khor, T. O.; Wang, H.; Kong, A. N. Sulforaphane suppressed LPS-induced inflammation in mouse peritoneal macrophages through Nrf2 dependent pathway. Biochem. Pharmacol. 2008, 76 (8), 967-973.
60. Woo, K. J.; Kwon, T. K. Sulforaphane suppresses lipopolysaccharide- induced cyclooxygenase-2 (COX-2) expression through the modulation of multiple targets in COX-2 gene promoter, Int. Immunopharmacol. 2007, 7(13), 1776-1783.
61. Murakami, A.; Song, M.; Ohigashi, H. Phenethyl isothiocyanate suppresses receptor activator of NF-κB ligand (RANKL)-induced osteodastogenesis by blocking activation of ERK1/2 and p38 MAPK in RAW264.7 macrophages. Biofactors 2007, 30 (1), 1-11.
62. Jeong, W. S.; Kim, 1. W.; Hu, R.; Kong, A. N. Modulatory properties of various natural chemopreventive agents on the activation of NF-κB signaling pathway. Pharm. Res. 2004, 21 (4), 661-670.
63. Nakamura, Y.; Miyoshi, N.; Takabayashi, S.; Osawa, T. Benzyl isothiocyanate inhibits oxidative stress in mouse skin: involvement of attenuation of leukocyte infiltration. Biofactors 2004, 21 (1-4), 255-257.
64. Miyoshi, N.; Takabayashi, S.; Osawa, T.; Nakamura, Y. Benzyl isothiocyanate inhibits excessive superoxide generation in inflammatory leukocytes: implication for prevention against inflammation-related carcinogenesis. Carcinogenesis 2004, 25 (4), 567-575.
65. Hou, D. X.; Masuzaki, S.; Hashimoto, F.; Uto, T.; Tanigawa, S.; Fujii, M.; Sakata, Y. Green tea proanthocyanidins inhibit cyclooxygenase-2 expression in LPS-activated mouse macrophages: molecular mechanisms and structure-activity relationship. Arch. Biochem. Biophys. 2007, 460 (1), 67-74.
66. Hsieh, M. C.; Shen, Y. J.; Kuo, Y. H.; Hwang, L. S. Antioxidative activity and active components of longan (Dimocarpus longan Lour.) flower extracts. J. Agric. Food Chem. 2008, 56, 7010-7016.
67. Akihisa, T.; Yasukawa, K.; Yamaura, M.; Ukiya, M.; Kimura, Y.; Shimizu, N.; Arai, K. Triterpene alcohol and sterol ferulates from rice bran and their anti-inflammatory effects. J. Agric. Food Chem. 2000, 45, 2313-2319.
68. Cheng, H. M.; Hsiang, C. Y.; Chen, G. W.; Wu, S. L.; Chen, J. C.; Huang, C. Y.; Bau, D. T.; Ho, T. Y. Inhibition of lipopolysacchar-ide-induced interleukin-1β and tumor necrosis factor-α production by menthone through nuclear factor-κB signaling pathway in HaCat cells. Chin. J. Physiol. 2008, 51 (3), 160-166.
69. Tsai, Y. C.; Chang, H. W.; Chang, T. T.; Lee, M. S.; Chu, Y. T.; Hung, C. H. Effects of all-trans retinoic acid on Th1- and Th2-related chemokines production in monocytes. Inflammation 2008, 31 (6), 428-433.
70. Hung, L. F.; Lai, J. H.; Lin, L. C.; Wang, S. J.; Hou, T. Y.; Chang, D. M.; Liang, C. C.; Ho, L. J. Retinoid acid inhibits IL-1-induced iNOS, COX-2 and chemokine production in human chondrocytes. Immunol. Invest. 2008, 37 (7), 675-693.
71. Kundu, J. K.; Shin, Y. K.; Surh, Y. J. Resveratrol modulates phorbol ester-induced pro-inflammatory signal transduction pathways in mouse skin in vivo: NF-κB and AP-1 as prime targets. Biochem. Pharmacol. 2006, 72(11), 1506-1515.
72. Kundu, J. K.; Shin, Y. K.; Kim, S. H.; Surh, Y. J. Resveratrol inhibits phorbol ester-induced expression of COX-2 and activation of NF-κB in mouse skin by blocking I/cB kinase activity. Carcinogenesis 2006, 27 (7), 1465-1474.
73. Wung, B. S.; Hsu, M. C.; Wu, C. C.; Hsieh, C. W. Resveratrol suppresses IL-6-induced ICAM-1 gene expression in endothelial cells: effects on the inhibition of STAT3 phosphorylation. Life Sci. 2005, 78 (4), 389-397.
74. Pan, M. H.; Chang, Y. H.; Tsai, M. L.; Lai, C. S.; Ho, S. Y.; Badmaev, V.; Ho, C. T. Pterostilbene suppressed lipopolysacchar-ide-induced up-expression of iNOS and COX-2 in murine macrophages. J. Agric. Food Chem. 2008, 56, 7502-7509.
75. Cichocki, M.; Paluszczak, J.; Szaefer, H.; Piechowiak, A.; Rimando, A. M.; Baer-Dubowska, W. Pterostilbene is equally potent as resveratrol in inhibiting 12-O-tetradecanoylphorbol-13-acetate activated NFκB, AP-1, COX-2, and iNOS in mouse epidermis. Mol. Nutr. Food Res. 2008, 52 (Suppl, 1), S62-S70.
76. Kim, Y. S.; Ahm, Y.; Hong, M. H.; Joo, S. Y.; Kim, K. H.; Sohn, I. S.; Park, H. W.; Hong, Y. J.; Kim, J. H.; Kim, W.; Jeong, M. H.; Cho, J. G.; Park, J. C.; Kang, J. C. Curcumin attenuates inflammatory responses of TNF-α-stimulated human endothelial cells. J. Cardiovasc. Pharmacol. 2007, 50 (1), 41-49.
77. Garg, R.; Ramchandani, A. G.; Marti, G. B. Curcumin decreases 12-O-tetradecanoylphorbol-13-acetate-induced protein kinase C translocation to modulate downstream targets in mouse skin. Carcinogenesis 2008, 29 (6), 1249-1257.
78. Kim, S. O.; Kundu, J. K.; Shin, Y. K.; Park, J. H.; Cho, M. H.; Kim, T. Y.; Surh, Y. J. [6]-Gingerol inhibits COX-2 expression by blocking the activation of p38 MAP kinase and NF-κB in phorbol ester-stimulated mouse skin. Oncogene 2005, 24 (15), 2558-2567.
79. Pan, M. H.; Hsieh, M. C.; Hsu, P. C.; Ho, S. Y.; Lai, C. S.; Wu, H.; Sang, S.; Ho, C. T. 6-Shogaol suppressed lipopolysaccharide-in-duced up-expression of iNOS and COX-2 in murine macrophages. Mol. Nutr. Food Res. 2008, 52 (12), 1467-1477.
80. Lo, A. H.; Liang, Y. C.; Lin-Shiau, S. Y.; Ho, C. T.; Lin, J. K. Carnosol, an antioxidant in rosemary, suppresses inducible nitric oxide synthase through down-regulating nuclear factor-κB in mouse macrophages. Carcinogenesis 2002, 23 (6), 983-991.
81. Subbaramaiah, K.; Cole, P. A.; Dannenberg, A. J. Retinoids and carnosol suppress cyclooxygenase-2 transcription by CREB-binding protein/p300-dependent and -independent mechanisms. Cancer Res. 2002, 62 (9), 2522-2530.
82. De, S. D.; Maiuri, M. C.; Simeon, V.; Grassia, G.; Soscia, A.; Cinelli, M. P.; Carnuccio, R. Lycopene, quercetin and tyrosol prevent macrophage activation induced by gliadin and IFN-γ. Eur. J. Pharmacol. 2007, 566 (1-3), 192-199.
83. Kim, G. Y.; Kim, J. H.; Ahn, S. C.; Lee, H. J.; Moon, D. O.; Lee, C. M.; Park, Y. M. Lycopene suppresses the lipopolysaccharide-in-duced phenotypic and functional maturation of murine dendritic cells through inhibition of mitogen-activated protein kinases and nuclear factor-κB. Immunology 2004, 113 (2), 203-211.
84. Bai, S. K.; Lee, S. 1; Na, H. J.; Ha, K. S.; Han, J. A.; Lee, H.; Kwon, Y. G.; Chung, C. K.; Kim, Y. M. β-Carotene inhibits inflammatory gene expression in lipopolysaccharide-stimulated macrophages by suppressing redox-based NF-κB activation. Exp. Mol. Med. 2005, 37 (4), 323-334.
85. Kim, J. H.; Na, H. J.; Kim, C. K.; Kim, J. Y.; Ha, K. S.; Lee, H.; Chung, H. T.; Kwon, H. J.; Kwon, Y. G.; Kim, Y. M. The non-provitamin A carotenoid, lutein, inhibits NF-κB-dependent gene expression through redox-based regulation of the phosphatidylinositol 3-kinase/PTEN/Akt and NF-κB-inducing kinase pathways: role of H(2)O(2) in NF-κB activation. Free Radical Biol. Med. 2008, 45 (6), 885-896.
86. Sasaki, M.; Ozawa, Y.; Kurihara, T.; Noda, K.; Imamura, Y.; Kobayashi, S.; Ishida, S.; Tsubota, K. Neuroprotective effect of an antioxidant, lutein, during retinal inflammation. Invest. Ophlhalmol. Vis. Sci. 2008.
87. Khan, M. N.; Cho, J. Y.; Lee, M. C.; Kang, J. Y.; Park, N. G.; Fujii, H.; Hong, Y. K. Isolation of two anti-inflammatory and one pro-inflammatory polyunsaturated fatty acids from the brown seaweed Undaria pinnatifida. J. Agric. Food Chem. 2007, 55, 6984-6988.
88. Xia, Y.; Feng, X.; Chen, Y.; Su, Y. [Effects of EPA, DHA on the secretion of NO, expression of iNOS mRNA and DNA-binding activity of NFκB in human monocyte]. Wei Sheng Yan. Jiu 2007, 36 (4), 445-448.
89. Moon, D. O.; Kim, K. C.; Jin, C. Y.; Han, M. H.; Park, C.; Lee, K. J.; Park, Y. M.; Choi, Y. H.; Kim, G. Y. Inhibitory effects of eicosapentaenoic acid on lipopolysaccharide-induced activation in BV2 microglia. Int. Immunopharmacol. 2007, 7 (2), 222-229.
90. Rahman, M. M.; Bhattacharya, A.; Fernandes, G. Docosahexaenoic acid is more potent inhibitor of osteoclast differentiation in RAW 264.7 cells than eicosapentaenoic acid. J. Cell Physiol. 2008, 214 (1), 201-209.
91. Ho, S. C.; Lin, C. C. Investigation of heat treating conditions for enhancing the anti-inflammatory activity of citrus fruit (Citrus reticulata) peels. J. Agric. Food Chem. 2008, 56, 7976-7982.
92. Wang, J.; Mazza, G. Inhibitory effects of anthocyanins and other phenolic compounds on nitric oxide production in LPS/IFN-γ-activated RAW 264.7 macrophages. J. Agric. Food Chem. 2002, 50, 850-857.
93. Hou, D. X.; Luo, D.; Tanigawa, S.; Hashimoto, F.; Uto, T.; Masuzaki, S.; Fujii, M.; Sakata, Y. Prodelphinidin B-4 3′-O-gallate, a tea polyphenol, is involved in the inhibition of COX-2 and iNOS via the downregulation of TAK1-NF-κB pathway. Biochem. Pharmacol. 2007, 74(5), 742-751.
94. Djoko, B.; Chiou, R. Y.; Shee, J. J.; Liu, Y. W. Characterization of immunological activities of peanut stilbenoids, arachidin-1, picea-tannol, and resveratrol on lipopolysaccharide-induced inflammation of RAW 264.7 macrophages. J. Agric. Food Chem. 2007, 55, 2376-2383.